Skip to main content
Caplight Logo









FitnessGenes

FitnessGenes

Private
BicesterHealthcare & Life Scienceshttps://fitnessgenes.com

Last Round

Series A

May 31, 2017

Total Funding Raised

$5.85M

Company Overview

FitnessGenes operates in Healthcare & Life Sciences and is based in Bicester. Its latest recorded funding round was a Series A round in May 2017.

FitnessGenes is a health and wellness company that provides personalized DNA testing and genetic analysis services to optimize fitness, nutrition, and health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Sports & Fitness, D2C Brands, Biotechnology

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

FitnessGenes Comparables

Compare FitnessGenes with similar companies based on industry and business-model similarity.

FitnessGenes comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Muhdo Health
87%
GenoPalate, Inc.
84%
Evogenom Oy
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

FitnessGenes Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 31, 2017
GrantOct 1, 2015
AngelJul 22, 2014
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Sam Decombel

Co-founder and Chief Executive Officer

Founding Team

For institutional investors. Book with your work email.

FitnessGenes Investors

Notable investors and investment history

FitnessGenes investors
InvestorRounds
Angels Den FundingAngel
Innovate UKGrant
High-Tech GründerfondsSeries A

FitnessGenes Filings

Explore SEC and related filing metadata, where available.

FitnessGenes filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about FitnessGenes's valuation, stock price, and market status.

Is FitnessGenes a public or private company?

FitnessGenes is a private company.

What is the current stock price of FitnessGenes?

FitnessGenes is a private company, so its shares have no public market price. Caplight tracks FitnessGenes's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is FitnessGenes worth (valuation)?

Valuation information for FitnessGenes is not publicly available.

Can I buy FitnessGenes stock?

FitnessGenes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was FitnessGenes's last funding round?

FitnessGenes's most recent funding round was Series A on May 31, 2017.

Who are the main investors in FitnessGenes?

Key investors in FitnessGenes include Angels Den Funding, Innovate UK, High-Tech Gründerfonds.

Will FitnessGenes IPO soon?

No public IPO plans have been announced for FitnessGenes.

How can I track FitnessGenes secondary market activity?

Caplight tracks bids, offers, and trades in FitnessGenes's shares on secondary markets.

Firmographic Details

HeadquartersBicester
Employee Range15
Year Founded2013
Last FundingMay 31, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?